Sorafenib Tablets
Multikinase Inhibitor / Oncology
Sorafenib Tablets
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Sorafenib Tablets (Sorafekast). High-quality, reliable, affordable medicine.
Formulation
Tablets
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
Finished Commercial Brand
Available finished formulation under our brand name Sorafekast.
View Commercial Product Details
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Sorafenib Tablets
Classification: Multikinase Inhibitor / Oncology
About Sorafenib Tablets
Sorafenib is an oral multikinase inhibitor targeting VEGFR, PDGFR, and RAF kinases, prescribed for primary kidney cancer (advanced renal cell carcinoma), advanced liver cancer (hepatocellular carcinoma), and radioactive iodine-resistant thyroid carcinoma.
Sorafenib Tablets (Sorafekast) Manufactured by Aprazer Healthcare
Sorafekast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.